Calcitonin treatment in lumbar spinal stenosis: A meta-analysis

Spine

Volumn 36, Issue 5, 2011, Pages

  Podichetty, Vinod K ^a   Varley, Eric S ^a   Lieberman, Isador ^a  

^a DEPARTMENT OF COLORECTAL SURGERY   (United States)

Author keywords

colcitonin; lumber spinal stenosis; neurogenic claudication; spine disorders

Indexed keywords

CALCITONIN; PLACEBO;

COCHRANE LIBRARY; CORRELATION ANALYSIS; DRUG EFFICACY; DRUG QUALITY; EMBASE; FOLLOW UP; HUMAN; LUMBAR SPINE; LUMBAR SPINE STENOSIS; MEDLINE; META ANALYSIS; OUTCOME ASSESSMENT; PRIORITY JOURNAL; PROSPECTIVE STUDY; REVIEW; SENSITIVITY ANALYSIS; SYSTEMATIC REVIEW; UNSPECIFIED SIDE EFFECT; VERTEBRAL CANAL STENOSIS; VISUAL ANALOG SCALE;

CALCITONIN; HUMANS; LUMBAR VERTEBRAE; PAIN MEASUREMENT; RANDOMIZED CONTROLLED TRIALS AS TOPIC; SPINAL STENOSIS; TREATMENT OUTCOME;

EID: 79952305440     PISSN: 03622436     EISSN: 15281159     Source Type: Journal    
DOI: 10.1097/BRS.0b013e318201b834     Document Type: Review

References (30)

1. Yaksi A, Ozgonenel L, Ozgonenel B. The effi ciency of gabapentin therapy in patients with lumbar spinal stenosis. Spine (Phila Pa 1976) 2007;32:939-42.
2. Johnsson KE, Rosen I, Uden A. The natural course of lumbar spinal stenosis. Acta Orthop Scand Suppl 1993;251:67-8. (Pubitemid 23098129)
3. Atlas SJ, Keller RB, Wu YA, et al. Long-term outcomes of surgical and nonsurgical management of lumbar spinal stenosis: 8 to 10 year results from the Maine lumbar spine study. Spine (Phila Pa 1976) 2005;30:936-43.
4. Cherkin DC, Deyo RA, Loeser JD, et al. An international comparison of back surgery rates. Spine (Phila Pa 1976) 1994;19:1201-6.
5. Eskola A, Pohjolainen T, Alaranta H, et al. Calcitonin treatment in lumbar spinal stenosis: a randomized, placebo-controlled, double-blind, cross-over study with one-year follow-up. Calcif Tissue Int 1992;50:400-3.
6. Podichetty VK, Segal AM, Lieber M, et al. Effectiveness of salmon calcitonin nasal spray in the treatment of lumbar canal stenosis: a double-blind, randomized, placebo-controlled, parallel group trial. Spine (Phila Pa 1976) 2004;29:2343-9.
7. Porter RW, Miller CG. Neurogenic claudication and root claudication treated with calcitonin. A double-blind trial. Spine (Phila Pa 1976) 1988;13:1061-4.
8. Streifl er J, Hering R, Gadoth N. Calcitonin for pseudoclaudication in lumbar spinal stenosis. J Neurol Neurosurg Psychiatry 1989;52:543-4.
9. Tafazal SI, Ng L, Sell P. Randomised placebo-controlled trial on the effectiveness of nasal salmon calcitonin in the treatment of lumbar spinal stenosis. Eur Spine J 2007;16:207-12. (Pubitemid 46295196)
10. Blau LA, Hoehns JD. Analgesic effi cacy of calcitonin for vertebral fracture pain. Ann Pharmacother 2003;37:564-70. (Pubitemid 36389669)
11. Lyritis GP, Ioannidis GV, Karachalios T, et al. Analgesic effect of salmon calcitonin suppositories in patients with acute pain due to recent osteoporotic vertebral crush fractures: a prospective double-blind, randomized, placebo-controlled clinical study. Clin J Pain 1999;15:284-9. (Pubitemid 30004887)
12. Lyritis GP, Trovas G. Analgesic effects of calcitonin. Bone 2002;30:71S-4S.
13. Tsavaris N, Kopterides P, Kosmas C, et al. Analgesic activity of high-dose intravenous calcitonin in cancer patients with bone metastases. Oncol Rep 2006;16:871-5.
14. Laurian L, Oberman Z, Graf E, et al. Calcitonin induced increase in ACTH, beta-endorphin and cortisol secretion. Horm Metab Res 1986;18:268-71. (Pubitemid 16106758)
15. Pecile A. Calcitonin and relief of pain. Bone Miner 1992;16:187-9.
16. Fraioli F, Fabbri A, Gnessi L, et al. Subarachnoid injection of salmon calcitonin induces analgesia in man. Eur J Pharmacol 1982;78:381-2. (Pubitemid 12190703)
17. Pecile A, Ferri S, Braga PC, et al. Effects of intracerebroventricular calcitonin in the conscious rabbit. Experientia 1975;31:332-3.
18. Gennari C, Agnusdei D, Camporeale A. Use of calcitonin in the treatment of bone pain associated with osteoporosis. Calcif Tissue Int 1991;49(Suppl 2):S9-13.
19. Amundsen T, Weber H, Nordal HJ, et al. Lumbar spinal stenosis: conservative or surgical management?: A prospective 10-year study. Spine (Phila Pa 1976) 2000;25:1424-35; discussion 35-6.
20. Moher D, Cook DJ, Jadad AR, et al. Assessing the quality of reports of randomised trials: implications for the conduct of metaanalyses. Health Technol Assess 1999;3:i-iv, 1-98.
21. Jadad AR, Moore RA, Carroll D, et al. Assessing the quality of reports of randomized clinical trials: is blinding necessary? Control Clin Trials 1996;17:1-12. (Pubitemid 26120810)
22. Schulz KF, Chalmers I, Hayes RJ, et al. Empirical evidence of bias. Dimensions of methodological quality associated with estimates of treatment effects in controlled trials. JAMA 1995;273:408-12.
23. Moher D, Schulz KF, Altman DG. The CONSORT statement: revised recommendations for improving the quality of reports of parallel-group randomised trials. Clin Oral Investig 2003;7:2-7.
24. Hedges LV, Pigott TD. The power of statistical tests in meta-analysis. Psychol Methods 2001;6:203-17. (Pubitemid 33600378)
25. Egger M, Davey Smith G, Schneider M, et al. Bias in meta-analysis detected by a simple, graphical test. Bmj 1997;315:629-34. (Pubitemid 27387172)
26. Eskola A, Alaranta H, Pohjolainen T, et al. Calcitonin treatment in lumber spinal stenosis: clinical observations. Calcif Tissue Int 1989;45:372-4. (Pubitemid 20028366)
27. Onel D, Sari H, Donmez C. Lumber spinal stenosis: clinical/radiologic therapeutic evaluation in 145 patients. Conservative treatment or surgical intervention? Spine 1993;18:291-8. (Pubitemid 23063170)
28. Porter RW, Hibbert C. Calcitonin treatment for neurogenic claudication. Spine (Phila Pa 1976) 1983;8:585-92.
29. Combe B, Cohen C, Aubin F. Equivalence of nasal spray and subcutaneous formulations of salmon calcitonin. Calcif Tissue Int 1997;61:10-5. (Pubitemid 27262393)
30. Zikan V, Stepan JJ. Plasma type 1 collagen cross-linked C-telopeptide: a sensitive marker of acute effects of salmon calcitonin on bone resorption. Clin Chim Acta 2002;316:63-9. (Pubitemid 34028189)